Seer

Developer of proteomics platform for early detection of cancer and neurological diseases

placeSan Francisco, California, United States calendar_todayFounded 2017 groups89 employees language seer.bio

Registered entities

Social engagement

Social engagement: 13.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include Maverick Ventures, Invus, aMoon, Wing Venture Capital.

Investor typeCountShare
Venture capital1059%
Private equity16%
Bank & private debt16%
Other / undisclosed529%

Recent activity

1 Jul 2026
Event
fireside chat on mass spectrometry proteomics for translational research and drug development
26 Jun 2026
Event
Mass spectrometry-based proteomics webinar
15 Jun 2026
Event
Unbiased Plasma Proteomics Expands GWAS Insights
Coming soon